Marcos González
ORCID: 0000-0001-6637-1072Also affiliated with Universidad Autónoma de Nuevo León, Justus-Liebig-Universität Gießen, New York Hospital Queens, Complejo Hospitalario de Salamanca, Vall d'Hebron Hospital Universitari, Hospital Universitario Dr José Eleuterio Gonzalez, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer, Centro de Investigación Biomédica en Red de Cáncer, Vall d'Hebron Institute of Oncology, Columbia University, Des Moines University, Icahn School of Medicine at Mount Sinai
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome”.
Arancha Rodríguez-Caballero, M. Laura Gutiérrez, Carlos E. Pedreira, Miguel Alcoceba, Wendy Nieto +8 more
María García‐Álvarez, Alejandro Medina, Elham Askari, Verónica González-Calle, María Casanova +12 more
Berta Pons-Brun, Núria Russiñol, Heribert Playà-Albinyana, Tycho Baumann, Martí Duran‐Ferrer +25 more
Quang‐Kim Tran, Marcos González